JAMA· 2021Q1
Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US—December 14, 2020-January 18, 2021
- 488citations
- Q1SCImago
- 2021year
Short summary
An analysis of anaphylaxis reports following mRNA COVID-19 vaccination in the US (Dec 14, 2020 - Jan 18, 2021) identified 47 verified cases, with a rate of 2.5 cases per million doses administered.
AI-generated from the title and abstract; the full text is not read.
Key points
- 47 verified cases of anaphylaxis were reported after receiving mRNA COVID-19 vaccines.
- Anaphylaxis occurred at a rate of 2.5 cases per million doses administered.
- Most reactions happened within 30 minutes post-vaccination.
- The majority of individuals experiencing anaphylaxis were women.
AI-generated from the title and abstract; the full text is not read.
Abstract
This JAMA Insights review provides clinical details of anaphylactic reactions reported to and verified by the CDC in the first month of use of the Pfizer-BioNTech and Moderna COVID-19 vaccines in the US, December 14, 2020-January 18, 2021.
The authors' abstract, as published at the source. JAMA, 2021 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Immunology and Allergy
Immunology and AllergyMedicine